Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multicenter Study to Evaluate Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition

NCT05622812 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.

NCT NCT05622812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05622812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Evaluator-blinded, Parallel Group, no Treatment Controlled, Multicenter Study to Evaluate Effectiveness and Safety of Restylane Lyft Lidocaine for Jawline Definition
Lead sponsor
Galderma R&D
Phase
Not applicable
Overall status
Completed
Start date
February 16, 2023
Completion date
June 14, 2024
Enrollment
140 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

jawline definition